                         SEQUENCE LISTING

<110>  ARMO Biosciences, Inc.
       Oft, Martin
 
<120>  METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND 
       DISORDERS

<130>  ARMO-014WO

<150>  US 62/067,337
<151>  2014-10-22

<160>  29    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  1

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  2
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  2

Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg 
1               5                   10          


<210>  3
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  3

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  4
<211>  33
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  4

Lys Ala Leu Ala Trp Glu Ala Lys Leu Ala Lys Ala Leu Ala Lys Ala 
1               5                   10                  15      


Leu Ala Lys His Leu Ala Lys Ala Leu Ala Lys Ala Leu Lys Cys Glu 
            20                  25                  30          


Ala 
    


<210>  5
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  5

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  6
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  6

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  7
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  7

Arg Lys Lys Arg Arg Gln Arg Arg 
1               5               


<210>  8
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  8

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  9
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  9

Thr His Arg Leu Pro Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  10
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  10

Gly Gly Arg Arg Ala Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  11
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  11

Met Lys Trp Val Thr Phe Ile Ser Leu Leu Phe Leu Phe Ser Ser Ala 
1               5                   10                  15      


Tyr Ser 
        


<210>  12
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  12

Arg Gly Val Phe Arg Arg 
1               5       


<210>  13
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  13

Arg Gly Arg Arg 
1               


<210>  14
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  14

Arg Lys Arg Lys Lys Arg 
1               5       


<210>  15
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  15

Arg Lys Lys Arg 
1               


<210>  16
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  16

Arg Arg Arg Lys Lys Arg 
1               5       


<210>  17
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  this residue may be repeated at least once

<400>  17

Gly Ser Gly Gly Ser 
1               5   


<210>  18
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  this residue may be repeated at least once

<400>  18

Gly Gly Gly Ser 
1               


<210>  19
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  this residue may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  this stretch of residues may be repeated more than once

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  this residue may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  this residue may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  this residue may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  this residue may be repeated at least once

<400>  19

Gly Ser Gly Ser Gly 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  this stretch of residues may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  this residue may be repeated at least once

<400>  20

Gly Ser Gly Gly Ser 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  this stretch of residues may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  this residue may be repeated at least once

<400>  21

Gly Ser Gly Ser Gly 
1               5   


<210>  22
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  this stretch of residues may be repeated at least once

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  this residue may be repeated at least once

<400>  22

Gly Gly Gly Ser 
1               


<210>  23
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  23

Gly Gly Ser Gly 
1               


<210>  24
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  24

Gly Gly Ser Gly Gly 
1               5   


<210>  25
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  25

Gly Ser Gly Gly Gly 
1               5   


<210>  26
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  26

Gly Gly Gly Ser Gly 
1               5   


<210>  27
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide sequence

<400>  27

Gly Ser Ser Ser Gly 
1               5   


<210>  28
<211>  178
<212>  PRT
<213>  Homo sapiens

<400>  28

Met His Ser Ser Ala Leu Leu Cys Cys Leu Val Leu Leu Thr Gly Val 
1               5                   10                  15      


Arg Ala Ser Pro Gly Gln Gly Thr Gln Ser Glu Asn Ser Cys Thr His 
            20                  25                  30          


Phe Pro Gly Asn Leu Pro Asn Met Leu Arg Asp Leu Arg Asp Ala Phe 
        35                  40                  45              


Ser Arg Val Lys Thr Phe Phe Gln Met Lys Asp Gln Leu Asp Asn Leu 
    50                  55                  60                  


Leu Leu Lys Glu Ser Leu Leu Glu Asp Phe Lys Gly Tyr Leu Gly Cys 
65                  70                  75                  80  


Gln Ala Leu Ser Glu Met Ile Gln Phe Tyr Leu Glu Glu Val Met Pro 
                85                  90                  95      


Gln Ala Glu Asn Gln Asp Pro Asp Ile Lys Ala His Val Asn Ser Leu 
            100                 105                 110         


Gly Glu Asn Leu Lys Thr Leu Arg Leu Arg Leu Arg Arg Cys His Arg 
        115                 120                 125             


Phe Leu Pro Cys Glu Asn Lys Ser Lys Ala Val Glu Gln Val Lys Asn 
    130                 135                 140                 


Ala Phe Asn Lys Leu Gln Glu Lys Gly Ile Tyr Lys Ala Met Ser Glu 
145                 150                 155                 160 


Phe Asp Ile Phe Ile Asn Tyr Ile Glu Ala Tyr Met Thr Met Lys Ile 
                165                 170                 175     


Arg Asn 
        


<210>  29
<211>  178
<212>  PRT
<213>  Mus musculus

<400>  29

Met Pro Gly Ser Ala Leu Leu Cys Cys Leu Leu Leu Leu Thr Gly Met 
1               5                   10                  15      


Arg Ile Ser Arg Gly Gln Tyr Ser Arg Glu Asp Asn Asn Cys Thr His 
            20                  25                  30          


Phe Pro Val Gly Gln Ser His Met Leu Leu Glu Leu Arg Thr Ala Phe 
        35                  40                  45              


Ser Gln Val Lys Thr Phe Phe Gln Thr Lys Asp Gln Leu Asp Asn Ile 
    50                  55                  60                  


Leu Leu Thr Asp Ser Leu Met Gln Asp Phe Lys Gly Tyr Leu Gly Cys 
65                  70                  75                  80  


Gln Ala Leu Ser Glu Met Ile Gln Phe Tyr Leu Val Glu Val Met Pro 
                85                  90                  95      


Gln Ala Glu Lys His Gly Pro Glu Ile Lys Glu His Leu Asn Ser Leu 
            100                 105                 110         


Gly Glu Lys Leu Lys Thr Leu Arg Met Arg Leu Arg Arg Cys His Arg 
        115                 120                 125             


Phe Leu Pro Cys Glu Asn Lys Ser Lys Ala Val Glu Gln Val Lys Ser 
    130                 135                 140                 


Asp Phe Asn Lys Leu Gln Asp Gln Gly Val Tyr Lys Ala Met Asn Glu 
145                 150                 155                 160 


Phe Asp Ile Phe Ile Asn Cys Ile Glu Ala Tyr Met Met Ile Lys Met 
                165                 170                 175     


Lys Ser 
        


